268 related articles for article (PubMed ID: 17846443)
1. Treating hypertriglyceridemia.
Yavasoglu I; Kadikoylu G; Bolaman Z
CMAJ; 2007 Sep; 177(6):603-4; author reply 604-5. PubMed ID: 17846443
[No Abstract] [Full Text] [Related]
2. Treating hypertriglyceridemia.
Röggla G; Fasan M; Kapiotis S
CMAJ; 2007 Sep; 177(6):603; author reply 604-5. PubMed ID: 17846444
[No Abstract] [Full Text] [Related]
3. Treating hypertriglyceridemia.
Holub BJ
CMAJ; 2007 Sep; 177(6):604; author reply 604-5. PubMed ID: 17846446
[No Abstract] [Full Text] [Related]
4. Clinical practice. Hypertriglyceridemia.
Brunzell JD
N Engl J Med; 2007 Sep; 357(10):1009-17. PubMed ID: 17804845
[No Abstract] [Full Text] [Related]
5. Hypertriglyceridemia and cardiovascular disease management.
Codario RA
J Am Acad Nurse Pract; 2007; 19(12 Suppl 2):7-10, 13-4. PubMed ID: 18510282
[No Abstract] [Full Text] [Related]
6. Hypertriglyceridemia: its etiology, effects and treatment.
Yuan G; Al-Shali KZ; Hegele RA
CMAJ; 2007 Apr; 176(8):1113-20. PubMed ID: 17420495
[TBL] [Abstract][Full Text] [Related]
7. First-line therapies for lowering triglyceride levels.
Raghavan VA
Am Fam Physician; 2008 Feb; 77(4):416; author reply 417-8. PubMed ID: 18326158
[No Abstract] [Full Text] [Related]
8. Management of hypertriglyceridemia.
Oh RC; Lanier JB
Am Fam Physician; 2007 May; 75(9):1365-71. PubMed ID: 17508532
[TBL] [Abstract][Full Text] [Related]
9. A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
Malloy MJ; Kane JP
Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072
[TBL] [Abstract][Full Text] [Related]
10. Bridging the gap in treatment options for patients with hypertriglyceridemia.
Underberg JA; Hays R
J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339
[TBL] [Abstract][Full Text] [Related]
11. Chylomicronemia and the chylomicronemia syndrome: a practical approach to management.
Leaf DA
Am J Med; 2008 Jan; 121(1):10-2. PubMed ID: 18187065
[TBL] [Abstract][Full Text] [Related]
12. [Hypertricglyceridemia: prognostic impact and treatment options].
Custodis F; Laufs U
Dtsch Med Wochenschr; 2011 Jul; 136(30):1533-42. PubMed ID: 21789752
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia: management of atherogenic dyslipidemia.
Bersot T; Haffner S; Harris WS; Kellick KA; Morris CM
J Fam Pract; 2006 Jul; 55(7):S1-8. PubMed ID: 16822443
[TBL] [Abstract][Full Text] [Related]
14. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
Gorkin JU; Watson K; Knopp RH
J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
[No Abstract] [Full Text] [Related]
15. Clinical practice. Low HDL cholesterol levels.
Ashen MD; Blumenthal RS
N Engl J Med; 2005 Sep; 353(12):1252-60. PubMed ID: 16177251
[No Abstract] [Full Text] [Related]
16. Drugs for lipids.
Treat Guidel Med Lett; 2005 Mar; 3(31):15-22. PubMed ID: 15726011
[No Abstract] [Full Text] [Related]
17. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
18. Hypertriglyceridemia: A review of the evidence.
Elkins C; Friedrich D
Nurse Pract; 2018 Oct; 43(10):22-29. PubMed ID: 30153192
[TBL] [Abstract][Full Text] [Related]
19. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
Alagona P
Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
[TBL] [Abstract][Full Text] [Related]
20. Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review.
Plaisance EP; Grandjean PW; Mahurin AJ
Phys Sportsmed; 2009 Apr; 37(1):11-9. PubMed ID: 20048483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
